Skip to content
LH Laboratory Corp of America Holdings NYSE
217.57 USD -1.44% -3.17
OPEN 219.18
DAY RANGE 219.67 - 216.97
52 WEEK RANGE 263.13 - 200.32
Interactive Brokers Logotype

Buy LH stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 19.3B
Enterprise value 25.3B
Trailing pe 19.797089
Forward pe 11.665953
Peg ratio 11.665953
Price to sales ttm 1.3064433
Price to book mrq 1.8640177
Enterprise to revenue 1.712
Enterprise to ebitda 10.898


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.0678
Operating margin 0.12039
Return on assets ttm 0.054250002
Return on equity ttm 0.09495
Income statement
Revenue ttm 14.8B
Revenue per share ttm 164.128
Quarterly revenue growth -0.031
Gross profit ttm 4.4B
Ebitda 2.4B
Net income to common ttm 1B
Diluted eps ttm 10.99
Quarterly earnings growth yoy -0.567
Balance sheet
Total cash mrq 393.9M
Total cash per share mrq 4.446
Total debt mrq 6.4B
Total debt to equity mrq 61.372
Current ratio mrq 1.627
Book value per share mrq 116.721
Cash flow
Operating cash flow ttm 1.7B
Levered free cash flow ttm 1B

Stock statistics

Shares outstanding 88.6M
Float shares 88.3M
Avg 10 volume 621.8K
Avg 30 volume 578.4K
Shares short 1.6M
Short ratio 2.81
Short percent of shares outstanding 0.0248
Percent held by insiders 0.0027599998
Percent held by institutions 0.93054

Stock price summary

Fifty two week low 200.32
Fifty two week high 263.13
Fifty two week change 0.538
Beta 1.042927
Day 50 ma 223.6068
Day 200 ma 229.7139

Dividends and splits

Forward annual dividend rate 2.88
Forward annual dividend yield 0.013099999
Trailing annual dividend rate 2.88
Trailing annual dividend yield 0.013047024
Payout ratio 0.2588
Dividend date 2023-06-08
Ex dividend date 2023-05-17
Last split factor 2-for-1 split
Last split date 2002-05-13

Laboratory of America Holdings (LH) company profile

Laboratory Corp. of America Holdings (NYSE: LH) is a life sciences company offering clinical laboratory and end-to-end drug development services. Its services and products aim to advance patient health and power clear, confident decisions through its diagnostics. It operates through the segments of Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD), serving doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers.